Expert suggestion for diabetes management during the recent COVID-19 pandemic

doi:10.16150/j.1671-2870.2022.02.006

Abstract

Abstract:

Recently, a new Omicron wave of coronavirus disease 2019(COVID-19) pandemic appeared in many places worldwide. Diabetes is one of the important risk factors affecting the severity including mortality of COVID-19. Optimal management of blood glucose and other metabolic parameters is crucial for patients with diabetes. Therefore, this expert′s suggestion aims at providing necessary recommendation and guidance for the comprehensive multifactorial management (from infection prevention and treatment, to metabolic control targets achievement) of diabetes patients during the current COVID-19 pandemic.

Key words: COVID-19, Omicron, Diabetes mellitus, Glycemic control

CLC Number:

R587.1

Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for diabetes management during the recent COVID-19 pandemic[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 136-138.

References 12

[1]	中国国家卫生健康委员会. 新型冠状病毒肺炎诊疗方案(试行第九版)[J]. 国际流行病学传染病学杂志, 2022, 49(2):73-80.
	China National Health Commission. Diagnosis and treatment plan for novel coronavirus pneumonia (trial version 9)[J]. Int J Epidemiol Infect Dis, 2022, 49(2):73-80.
[2]	Zhang X, Zhang W, Chen S. Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic[J]. Lancet, 2022, 399(10340):2011-2012. doi: 10.1016/S0140-6736(22)00838-8 URL
[3]	Seiglie J, Platt J, Cromer SJ, et al. Diabetes as a Risk Factor for Poor Early Outcomes in Patients Hospitalized With COVID-19[J]. Diabetes Care, 2020, 43(12):2938-2944. doi: 10.2337/dc20-1506 URL
[4]	Barron E, Bakhai C, Kar P, et al. Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study[J]. Lancet Diabetes Endocrinol, 2020, 8(10):813-822. doi: 10.1016/S2213-8587(20)30272-2 URL
[5]	Hartmann-Boyce J, Rees K, Perring JC, et al. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews[J]. Diabetes Care, 2021, 44(12):2790-2811. doi: 10.2337/dc21-0930 pmid: 34711637
[6]	Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study[J]. Lancet, 2022, 399(10335):1618-1624. doi: 10.1016/S0140-6736(22)00327-0 URL
[7]	Yonekawa A, Shimono N. Clinical Significance of COVID-19 and Diabetes: In the Pandemic Situation of SARS-CoV-2 Variants including Omicron(B.1.1.529)[J]. Biology (Basel). 2022 Mar 4; 11(3):400.
[8]	Chan JCN, Lim LL, Wareham NJ, et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives[J]. Lancet, 2021, 396(10267):2019-2082. doi: 10.1016/S0140-6736(20)32374-6 URL
[9]	中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4):311-398.
	Diabetes branch of Chinese Medical Association. Guidelines for prevention and treatment of type 2 diabetes in China(2020 Edition)[J]. Chin J Endocrinol Metab, 2021, 37(4):311-398.
[10]	王卫庆, 单忠艳, 王广, 等. 新型冠状病毒肺炎疫情期间糖尿病基层管理专家建议[J]. 中华内分泌代谢杂志, 2020, 36(3):185-190.
	Wang WQ, Shan ZY, Wang G, et al. Expert advice on diabetes management at the grass-roots level during the outbreak of novel coronavirus pneumonia[J]. Chin J Endocrinol Metab, 2020, 36(3):185-190.
[11]	中国医师协会内分泌代谢科医师分会,中国住院患者血糖管理专家组. 中国住院患者血糖管理专家共识[J]. 中华内分泌代谢杂志, 2017, 33(1):1-10.
	Endocrinologist branch of Chinese Medical Association, Chinese inpatient blood glucose management expert group. Consensus of Chinese inpatient blood glucose management experts[J]. Chin J Endocrinol Metab, 2017, 33(1):1-10.
[12]	Zhang Y, Wang W, Ning G. Metabolic Management Center: An innovation project for the management of metabolic diseases and complications in China[J]. J Diabetes, 2019, 11(1):11-13. doi: 10.1111/1753-0407.12847 URL

[1]	SHI Feng, GUO Zhuying, GUO Haiyan. Clinical significance of changes in peripheral blood lymphocyte subsets in patients with novel coronavirus pneumonia [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(05): 619-624.
[2]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestions on the management of hyperthyroidism and hypothyroidism in the time of COVID-19 [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 128-129.
[3]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for pituitary disease management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 130-132.
[4]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for osteoporosis management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 133-135.
[5]	Chinese Society of Endocrinology,Chinese Medical Association , et al . Expert suggestion for adrenal diseases management during the recent COVID-19 pandemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 139-142.
[6]	CHEN Changqiang, MENG Jun, JIN Peipei, DAI Jing, et al . Practice and exploration of novel coronavirus nucleic acid detection in designated hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 143-149.
[7]	ZHUANG Lei, ZHENG Ruizhi, GAO Weiyi, et al . Analysis on the epidemic situation of COVID-19 by Omicron variant in a single office building [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 150-153.
[8]	ZHANG Feng, YANG Jing, YAN Yue, CHEN Weihong, CAI Zhengyu, LIU Xiying, CHENG Jie, WAN Jin, XI Jing, YANG Zhitao, QIU Liping, CHEN Erzhen. Analysis and suggestions on petition status of Fangcang and designated hospitals during COVID-19 epidemic [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 160-164.
[9]	ZHANG Yibo, WU Wenjuan, BI Yufang, JING Feng, GU Zhidong, YANG Zhitao, SHANG Hanbing, LIN Jingsheng, CHEN Erzhen. Construction and practice of infection prevention and control system in large Fangcang shelter hospitals [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 165-168.
[10]	LOU Jiao, JIANG Lingli, WANG Yin, ZHOU Jing, HU Xiaobo, WANG Qing, et al . Exploration of quality control methods for regional COVID-19 nucleic acid detection laboratories [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 174-177.
[11]	SHI Yingying, ZHONG Xu, LIU Jialin, HE Le, XIONG Shaoji, WENG Y, DING Chengwei, YANG Y, CHEN Weihon, QIU Liping, XIN Haiguang. Hospital infection prevention and control practices in anti-epidemic medical staff and workers during COVID-19 epidemic: investigation and countermeasures [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 178-183.
[12]	JIANG Yan, CHEN Ting, HUANG Chen, PAN Peiqian, JING Feng, et al . Construction and practice of emergency response capability training program for all staff in emergency medical ward under COVID-19：Emergency response strategy [J]. Journal of Diagnostics Concepts & Practice, 2022, 21(02): 189-195.
[13]	GU Qin, WANG Tairong, CHEN Liping, WU Shuyao, SHEN Yi. Investigation on common pathogens and related risk factors of urinary tract infection in elderly female diabetic patients in community [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(05): 538-542.
[14]	ZHANG Yiyun, XU Lei, TANG Zhaosheng, CHEN Yinghua, DOU Qin, FENG Bo. Clinical characteristics of type 2 diabetes complicated with hepatitis E [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(05): 557-561.
[15]	JI Pengcheng, ZHANG Shu, SUN Jing, JIANG Shihu. Analysis on levels of vitamins in middle-aged and elderly patients with diabetes mellitus in Shanghai [J]. Journal of Diagnostics Concepts & Practice, 2018, 17(03): 285-289.